AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11273913 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural anesthesia (TEA) combined with general anesthesia (GA) using bupivacaine 0.5% and low-dose isoflurane (0.3-0.5 vol%)
Number of subjects: 50
Study 9161112 — intervention group
Group type: EXPERIMENTAL
Intervention: Spina bifida health-related quality of life (HRQOL) instrument
Number of subjects: 329
Study 8510388 — intervention group
Group type: EXPERIMENTAL
Intervention: KCl (80 mmol/day)
Number of subjects: 8
Study 8510388 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 2442323 — intervention group
Group type: EXPERIMENTAL
Intervention: RT plus CT (bleomycin and methotrexate)
Number of subjects: 104
Study 2442323 — intervention group
Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 104
Study 31840248 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-distancing
Number of subjects: 149
Study 31840248 — intervention group
Group type: COMPARATOR
Intervention: Self-immersed
Number of subjects: 149
Study 29715227 — intervention group
Group type: COMPARATOR
Intervention: Closed Reduction and Percutaneous Pinning (CRPP)
Number of subjects: 40
Study 29715227 — intervention group
Group type: EXPERIMENTAL
Intervention: Open Reduction and Internal Fixation (ORIF)
Number of subjects: 40
Study 29715227 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall costs
Number of subjects: 40
Study 30265463 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cruroraphy (group I)
Number of subjects: 0
Study 24993695 — intervention group
Group type: EXPERIMENTAL
Intervention: green-plant membranes (5 g)
Number of subjects: 38
Study 24993695 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 38
Study 22903139 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoload (IL) eccentric resistance training
Number of subjects: 31
Study 22903139 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic (IK) eccentric resistance training
Number of subjects: 31
Study 22903139 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 31
Study 21715226 — intervention group
Group type: EXPERIMENTAL
Intervention: Alzheimer's disease (AD)
Number of subjects: 118
Study 21715226 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (HC)
Number of subjects: 118
Study 17993663 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey on radon awareness
Number of subjects: 3600
Study 17252888 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice‐daily atomoxetine
Number of subjects: 85
Study 17252888 — intervention group
Group type: COMPARATOR
Intervention: Thrice‐daily methylphenidate
Number of subjects: 85
Study 17252888 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 85
Study 17252888 — intervention group
Group type: COMPARATOR
Intervention: Methylphenidate
Number of subjects: 85
Study 14501737 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 80 mg daily (40 mg twice daily for 12 weeks)
Number of subjects: 683
Study 14501737 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 683
Study 14501737 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 80 mg daily
Number of subjects: 683
Study 10843241 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic renal failure patients
Number of subjects: 6
Study 10843241 — intervention group
Group type: COMPARATOR
Intervention: Healthy individuals (control group)
Number of subjects: 6
Study 9217897 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute insulin-glucose infusion followed by multidose subcutaneous insulin
Number of subjects: 620
Study 9217897 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intensive insulin treatment)
Number of subjects: 620
Study 8403901 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper T-380A IUD
Number of subjects: 2166
Study 3829934 — intervention group
Group type: EXPERIMENTAL
Intervention: horse‐ALG and horse‐ATG
Number of subjects: 42
Study 3829934 — intervention group
Group type: EXPERIMENTAL
Intervention: rabbit‐ATG
Number of subjects: 42
Study 3829934 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin A
Number of subjects: 42
Study 3829934 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 42
Study 29477588 — intervention group
Group type: COMPARATOR
Intervention: High-frequency left-sided rTMS (n = 21)
Number of subjects: 113
Study 29477588 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency right-sided rTMS (n = 18)
Number of subjects: 113
Study 29477588 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential bilateral rTMS (n = 20)
Number of subjects: 113
Study 27496229 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-individualised Chinese medicine treatment for 48 weeks
Number of subjects: 148
Study 27496229 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 148
Study 23836493 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT)
Number of subjects: 45
Study 23836493 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 45
Study 23836493 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Aerobic and Resistance Training (AT+RT)
Number of subjects: 45
Study 22449900 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of metal filter in FPD during X-ray exposure
Number of subjects: 40
Study 20565376 — intervention group
Group type: EXPERIMENTAL
Intervention: Genzyme (Thymoglobulin: ATG‐G; 6.2 +/‐ 2.9 mg/kg for 7 days)
Number of subjects: 16
Study 20565376 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresenius (Lymphoglobulin: ATG‐F; 22.6 +/‐ 7.9 mg/kg for 6 days)
Number of subjects: 16
Study 20565376 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 16
Study 18988154 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 1.5% eye-drops, twice daily for 3 days
Number of subjects: 1043
Study 18988154 — intervention group
Group type: COMPARATOR
Intervention: Tobramycin 0.3% eye-drops, every 2 hours while awake for 2 days, then four times daily for 5 days
Number of subjects: 1043
Study 20159729 — intervention group
Group type: EXPERIMENTAL
Intervention: Danqi Huogan Capsule in addition to routine therapies
Number of subjects: 104
Study 20159729 — intervention group
Group type: COMPARATOR
Intervention: Routine therapies for liver protection
Number of subjects: 104
Study 15480740 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (EXP) performing exhaustive SSC exercise
Number of subjects: 6
Study 15480740 — intervention group
Group type: COMPARATOR
Intervention: Control group (C) not performing SSC exercise
Number of subjects: 6
Study 12399262 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat-substituted diet (one-third of dietary fat replaced by olestra to achieve a diet containing 25% metabolizable fat)
Number of subjects: 45
Study 12399262 — intervention group
Group type: COMPARATOR
Intervention: Control diet (33% fat)
Number of subjects: 45
Study 12399262 — intervention group
Group type: COMPARATOR
Intervention: Fat-reduced diet (25% fat)
Number of subjects: 45
Study 12399262 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between fat-reduced and fat-substituted groups
Number of subjects: 45
Study 12399262 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between control and fat-substituted groups
Number of subjects: 45
Study 12399262 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between control and fat-reduced groups
Number of subjects: 45
Study 9538773 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine collection pads
Number of subjects: 0
Study 9538773 — intervention group
Group type: COMPARATOR
Intervention: Clean-catch method using sterile foil bowls
Number of subjects: 0
Study 8005276 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot form of triptoreline (3.75 mg IM injection)
Number of subjects: 196
Study 8005276 — intervention group
Group type: COMPARATOR
Intervention: Standard release form of triptoreline (0.1 mg SC daily)
Number of subjects: 196
Study 8005276 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Depot and Standard release)
Number of subjects: 196
Study 2688533 — intervention group
Group type: EXPERIMENTAL
Intervention: Iopromide 300 (brain) and 370 (whole body)
Number of subjects: 165
Study 2688533 — intervention group
Group type: COMPARATOR
Intervention: Ioxaglate 320
Number of subjects: 165
Study 4215536 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-release iron
Number of subjects: 28
Study 4215536 — intervention group
Group type: COMPARATOR
Intervention: Ferrous sulphate
Number of subjects: 28
Study 4215536 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid
Number of subjects: 28
Study 11726845 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium phosphate tablets
Number of subjects: 845
Study 11726845 — intervention group
Group type: COMPARATOR
Intervention: PEG solution
Number of subjects: 845
Study 31300667 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient treatment
Number of subjects: 17
Study 31300667 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 30126094 — intervention group
Group type: EXPERIMENTAL
Intervention: Kiwifruit preload
Number of subjects: 0
Study 30126094 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice-split preload
Number of subjects: 0
Study 30126094 — intervention group
Group type: COMPARATOR
Intervention: Rice meal in one sitting
Number of subjects: 0
Study 27084279 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) + photodynamic therapy + oral hygiene (OH)
Number of subjects: 182
Study 27084279 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) + oral hygiene (OH)
Number of subjects: 182
Study 25276785 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined home exercise (COMB)
Number of subjects: 19
Study 25276785 — intervention group
Group type: COMPARATOR
Intervention: Range-of-motion home exercise (ROM)
Number of subjects: 19
Study 22797283 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium lozenges, administered 30 min preoperatively.
Number of subjects: 70
Study 22797283 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group), administered 30 min preoperatively.
Number of subjects: 70
Study 21200437 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan (80 mg/day)
Number of subjects: 25620
Study 21200437 — intervention group
Group type: COMPARATOR
Intervention: Ramipril (10 mg/day)
Number of subjects: 25620
Study 21200437 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 25620
Study 21200437 — intervention group
Group type: COMPARATOR
Intervention: Ramipril
Number of subjects: 25620
Study 17526320 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health education, mass media interventions, training of health professionals, health education through Lady Health Workers
Number of subjects: 0
Study 17526320 — intervention group
Group type: COMPARATOR
Intervention: Training of health care providers
Number of subjects: 0
Study 16003289 — intervention group
Group type: EXPERIMENTAL
Intervention: St John's wort (SJW) 300 mg LI 160 3 times daily
Number of subjects: 16
Study 16003289 — intervention group
Group type: COMPARATOR
Intervention: Control (no SJW)
Number of subjects: 16
Study 12462291 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha-n2b (5 MU subcutaneously once daily for 8 weeks, then 5 MU TIW for 48 weeks if HCV-RNA negative)
Number of subjects: 60
Study 12462291 — intervention group
Group type: COMPARATOR
Intervention: Control group (males without a history of drug addiction)
Number of subjects: 60
Study 12462291 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha-n2b (for heroin abusers)
Number of subjects: 60
Study 12462291 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine levels and activated CD11 antigen-expressing monocytes (for heroin abusers)
Number of subjects: 60
Study 10528972 — intervention group
Group type: EXPERIMENTAL
Intervention: Amalgam
Number of subjects: 49
Study 10528972 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin composite
Number of subjects: 49
Study 10528972 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-modified glass ionomer cement
Number of subjects: 49
Study 7473014 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing plus tetracycline fiber for 10 days (SF)
Number of subjects: 122
Study 7473014 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (S)
Number of subjects: 122
Study 7473014 — intervention group
Group type: COMPARATOR
Intervention: Fiber therapy alone for 10 days (F)
Number of subjects: 122
Study 7473014 — intervention group
Group type: COMPARATOR
Intervention: Fiber therapy alone for 20 days (FF)
Number of subjects: 122
Study 1782132 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive dietary management and treatment with pancreatic enzymes
Number of subjects: 0
Study 1782132 — intervention group
Group type: EXPERIMENTAL
Intervention: Males with cystic fibrosis
Number of subjects: 0
Study 1782132 — intervention group
Group type: EXPERIMENTAL
Intervention: Careful observation for nutritional abnormalities
Number of subjects: 0
Study 1782132 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention to vitamin E and essential fatty acid status
Number of subjects: 0
Study 1782132 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term consequences of early nutritional intervention
Number of subjects: 0
Study 7025721 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral trimethoprim-sulfamethoxazole treatment
Number of subjects: 29
Study 7025721 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 29
Study 31376708 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized sequenced Attention Bias Modification (ABM) followed by Applied Relaxation psychoeducation (AR‐pe)
Number of subjects: 169
Study 31376708 — intervention group
Group type: EXPERIMENTAL
Intervention: Reversed sequence of AR‐pe and ABM
Number of subjects: 169
Study 31376708 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous ABM and AR‐pe
Number of subjects: 169
Study 31376708 — intervention group
Group type: COMPARATOR
Intervention: Assessment only control group
Number of subjects: 169
Study 29031023 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration combined with treadmill training (WBV-TT)
Number of subjects: 30
Study 29031023 — intervention group
Group type: COMPARATOR
Intervention: Treadmill training (TT)
Number of subjects: 30
Study 26061572 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzocaine 20% topical anesthetic
Number of subjects: 38
Study 26061572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 24343322 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific stabilization exercise (SSE)
Number of subjects: 11
Study 24343322 — intervention group
Group type: EXPERIMENTAL
Intervention: General stabilization exercise (GSE)
Number of subjects: 11
Study 24343322 — intervention group
Group type: COMPARATOR
Intervention: Combined groups (SSE and GSE)
Number of subjects: 11
Study 23036123 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesitherapy
Number of subjects: 35
Study 19697825 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled continuous epidural analgesia (PCEA) with 0.125% bupivacaine and 0.2 microg kg(‐1) fentanyl (basic infusion 1 mL h(‐1), bolus 4 mL, lock‐out time 15 min)
Number of subjects: 52
Study 19697825 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil PCA (0.2 microg kg(‐1) bolus doses, without basic infusion, lock‐out time 2 min)
Number of subjects: 52
Study 19697825 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil PCA
Number of subjects: 52
Study 19697825 — intervention group
Group type: EXPERIMENTAL
Intervention: PCEA
Number of subjects: 52
Study 17896891 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin 200 mg every 8 hours for 7 days
Number of subjects: 27
Study 17896891 — intervention group
Group type: COMPARATOR
Intervention: Single-dose intravenous midazolam 2 mg
Number of subjects: 27
Study 17896891 — intervention group
Group type: COMPARATOR
Intervention: Single-dose oral midazolam 6 mg
Number of subjects: 27
Study 15111537 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11927450 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg morphine
Number of subjects: 60
Study 11927450 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 60
Study 9652875 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 30 mg/d for 1 year
Number of subjects: 2138
Study 9652875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2138
Study 7661159 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.i.d. with 1 g amoxicillin b.i.d.
Number of subjects: 52
Study 7661159 — intervention group
Group type: COMPARATOR
Intervention: High dose ranitidine (900 and 1800 mg) plus sodium bicarbonate tablets 650 t.i.d. with 1 g amoxicillin b.i.d.
Number of subjects: 52
Study 2475701 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine ER 20 mg
Number of subjects: 151
Study 2475701 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine ER 10 mg
Number of subjects: 151
Study 2475701 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study 21788 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine solution with adrenaline plus Betadrenol (beta-receptor blocker)
Number of subjects: 0
Study 21788 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine solution with adrenaline
Number of subjects: 0
Study 30333221 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision Support and Navigation Intervention (DSNI) Group
Number of subjects: 400
Study 30333221 — intervention group
Group type: COMPARATOR
Intervention: Standard Intervention (SI) Group
Number of subjects: 400
Study 28342739 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised physical therapy (PT)
Number of subjects: 74
Study 28342739 — intervention group
Group type: COMPARATOR
Intervention: Home exercise program (HEP)
Number of subjects: 74
Study 26260318 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based computer tailored intervention (Kanker Nazorg Wijzer) providing psychosocial and lifestyle support
Number of subjects: 462
Study 26260318 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 462
Study 24151273 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose radial extracorporeal shock-wave therapy (rESWT) - three sessions at an interval of 10 to 14 days, 2000 pulses, 0.11 mJ/mm², 8 Hz
Number of subjects: 82
Study 24151273 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 82
Study 21883902 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus (SRL)
Number of subjects: 121
Study 21883902 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine A (CsA)
Number of subjects: 121
Study 21883902 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclinical inflammation (SCI)
Number of subjects: 121
Study 19109542 — intervention group
Group type: EXPERIMENTAL
Intervention: mCIT + mental practice
Number of subjects: 10
Study 19109542 — intervention group
Group type: COMPARATOR
Intervention: mCIT only
Number of subjects: 10
Study 17967230 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine (loading dose of 60 mg followed by 20 mg 3 times daily for 2 weeks)
Number of subjects: 60
Study 17967230 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine
Number of subjects: 60
Study 17967230 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 15133344 — intervention group
Group type: EXPERIMENTAL
Intervention: OT+PR
Number of subjects: 71
Study 15133344 — intervention group
Group type: COMPARATOR
Intervention: PR
Number of subjects: 71
Study 11240234 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant hormone therapy (goserelin)
Number of subjects: 945
Study 11240234 — intervention group
Group type: COMPARATOR
Intervention: Radiation only
Number of subjects: 945
Study 9469326 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose EPO (2,000 U subcutaneously thrice weekly)
Number of subjects: 100
Study 9469326 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose EPO (10,000 U subcutaneously thrice weekly)
Number of subjects: 100
Study 9469326 — intervention group
Group type: COMPARATOR
Intervention: Patients not treated with chemotherapy (control group)
Number of subjects: 100
Study 8553821 — intervention group
Group type: EXPERIMENTAL
Intervention: Air‐Stirrup ankle brace
Number of subjects: 73
Study 8553821 — intervention group
Group type: COMPARATOR
Intervention: Compression bandage
Number of subjects: 73
Study 1967227 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol 80 mg bolus followed by 24 mg.min‐1 infusion
Number of subjects: 17
Study 1967227 — intervention group
Group type: COMPARATOR
Intervention: No esmolol
Number of subjects: 17
Study 361485 — intervention group
Group type: EXPERIMENTAL
Intervention: Sengstaken-Blakemore (SB) tube
Number of subjects: 79
Study 361485 — intervention group
Group type: COMPARATOR
Intervention: Linton-Nachlas (LN) tube
Number of subjects: 79
Study 29972085 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised controlled trial of psychotherapy for treatment-resistant depression
Number of subjects: 37
Study 31286931 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (youth-led education program)
Number of subjects: 512
Study 31286931 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 512
Study 29066863 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg MB12066 twice daily for 8 days
Number of subjects: 11
Study 29066863 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 25909794 — intervention group
Group type: EXPERIMENTAL
Intervention: ω‐3 polyunsaturated fatty acids (PUFAs), 1 capsule/day for three months
Number of subjects: 39
Study 25909794 — intervention group
Group type: COMPARATOR
Intervention: Traditional hypoglycemic therapy
Number of subjects: 39
Study 23707209 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal combination of Mentha longifolia, Cyperus rotundus, and Zingiber officinale
Number of subjects: 40
Study 23707209 — intervention group
Group type: COMPARATOR
Intervention: Mebeverine
Number of subjects: 40
Study 21924093 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic vidian neurectomy (group A)
Number of subjects: 191